These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1445599)

  • 1. Postantibiotic effect of amikacin and rifapentine against Mycobacterium avium complex.
    Bermudez LE; Wu M; Young LS; Inderlied CB
    J Infect Dis; 1992 Oct; 166(4):923-6. PubMed ID: 1445599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium.
    Horgen L; Legrand E; Rastogi N
    Res Microbiol; 1997 Nov; 148(8):673-81. PubMed ID: 9765852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro activity of clofazimine alone and in combination with amikacin, roxithromycin, rifampicin and rifapentine against Mycobacterium avium-intracellulare].
    Casal Román M; Rodríguez López F; Villalba Montoro R; González Requero AI
    Enferm Infecc Microbiol Clin; 1989 Oct; 7(8):432-5. PubMed ID: 2490859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postantibiotic effects of rifampin, amikacin, clarithromycin and ethambutol used alone or in various two-, three- and four-drug combinations against Mycobacterium avium.
    Horgen L; Legrand E; Rastogi N
    FEMS Immunol Med Microbiol; 1999 Jan; 23(1):37-44. PubMed ID: 10030545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
    Ferro BE; Meletiadis J; Wattenberg M; de Jong A; van Soolingen D; Mouton JW; van Ingen J
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1097-105. PubMed ID: 26643335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages.
    Perronne C; Gikas A; Truffot-Pernot C; Grosset J; Vilde JL; Pocidalo JJ
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1356-9. PubMed ID: 1656860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of CO2 generation (BACTEC) and viable-count methods to determine the postantibiotic effect of antimycobacterial agents against Mycobacterium avium complex.
    Zhanel GG; Saunders MH; Wolfe JN; Hoban DJ; Karlowsky JA; Kabani AM
    Antimicrob Agents Chemother; 1998 Jan; 42(1):184-7. PubMed ID: 9449284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial activity of subinhibitory concentrations of aminoglycosides against Pseudomonas aeruginosa as determined by the killing-curve method and the postantibiotic effect.
    Zhanel GG; Karlowsky JA; Hoban DJ; Davidson RJ
    Chemotherapy; 1991; 37(2):114-21. PubMed ID: 1903340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complex.
    Rastogi N; Goh KS; Bryskier A
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1433-8. PubMed ID: 8092850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sitafloxacin (DU-6859a) and trovafloxacin: postantibiotic effect and in vitro interactions with rifampin on methicillin-resistant Staphylococcus aureus.
    Giamarellou-Bourboulis EJ; Sambatakou H; Grecka P; Chryssouli Z; Giamarellou H
    Diagn Microbiol Infect Dis; 1999 Aug; 34(4):301-7. PubMed ID: 10459481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulsed-exposure and postantibiotic leukocyte enhancement effects of amikacin, clarithromycin, clofazimine, and rifampin against intracellular Mycobacterium avium.
    Horgen L; Jerome A; Rastogi N
    Antimicrob Agents Chemother; 1998 Nov; 42(11):3006-8. PubMed ID: 9797242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin.
    Bermudez LE; Wu M; Young LS
    J Infect Dis; 1987 Sep; 156(3):510-3. PubMed ID: 3611835
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination.
    Bakker-Woudenberg IA; van Vianen W; van Soolingen D; Verbrugh HA; van Agtmael MA
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2387-98. PubMed ID: 15917538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
    J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the post-antibiotic effect of six anti-mycobacterial agents against Mycobacterium avium by the Bactec radiometric method.
    Fuursted K
    J Antimicrob Chemother; 1997 Jul; 40(1):33-8. PubMed ID: 9249202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of free and liposome encapsulated amikacin on the survival of Mycobacterium avium complex in mouse peritoneal macrophages.
    Kesavalu L; Goldstein JA; Debs RJ; Düzgünes N; Gangadharam PR
    Tubercle; 1990 Sep; 71(3):215-7. PubMed ID: 2238129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postantibiotic effects and postantibiotic sub-MIC effects of ciprofloxacin, pefloxacin and amikacin on the biological properties of Salmonella strains.
    Majtán V; Majtánová L
    Folia Microbiol (Praha); 1997; 42(4):327-32. PubMed ID: 9449780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial Susceptibility of Clinical and Environmental Mycobacterium chimaera Isolates.
    Mok S; Hannan MM; Nölke L; Stapleton P; O'Sullivan N; Murphy P; McLaughlin AM; McNamara E; Fitzgibbon MM; Rogers TR
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262760
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complex.
    Klemens SP; Grossi MA; Cynamon MH
    Antimicrob Agents Chemother; 1994 Feb; 38(2):234-7. PubMed ID: 8192449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease.
    Ferro BE; van Ingen J; Wattenberg M; van Soolingen D; Mouton JW
    J Antimicrob Chemother; 2015 Oct; 70(10):2838-43. PubMed ID: 26142475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.